Mimedx Group INC (MDXG) Holder Tiedemann Wealth Management LLC Has Lowered Its Position

September 17, 2017 - By Marguerite Chambers

Investors sentiment increased to 1.22 in Q4 2016. Its up 0.07, from 1.15 in 2016Q3. It increased, as 16 investors sold MDXG shares while 47 reduced holdings. 23 funds opened positions while 54 raised stakes. 54.88 million shares or 0.33% more from 54.70 million shares in 2016Q3 were reported. Metropolitan Life Ins Commerce New York accumulated 0% or 68,373 shares. Lpl Financial Limited Liability Corp holds 0% of its portfolio in MiMedx Group Inc (NASDAQ:MDXG) for 24,799 shares. Raymond James Services Advsrs owns 54,718 shares. Summit Creek Advsrs Ltd Llc holds 1.4% or 926,825 shares in its portfolio. Tiaa Cref Management Ltd Limited Liability Company holds 0% in MiMedx Group Inc (NASDAQ:MDXG) or 378,309 shares. Tiedemann Wealth Mngmt Limited Liability Corp stated it has 1.6% in MiMedx Group Inc (NASDAQ:MDXG). Blackrock reported 8,837 shares. Amalgamated Commercial Bank holds 13,520 shares or 0.01% of its portfolio. Barclays Public Ltd Com accumulated 0% or 16,582 shares. Dupont Management reported 0.04% in MiMedx Group Inc (NASDAQ:MDXG). Ubs Asset Mngmt Americas invested in 0% or 74,013 shares. Tudor Invest Corporation Et Al invested 0% in MiMedx Group Inc (NASDAQ:MDXG). Merriman Wealth Ltd Liability Corp has 572,644 shares. California Pub Employees Retirement Sys stated it has 0% in MiMedx Group Inc (NASDAQ:MDXG). Macquarie Gp reported 2.93 million shares or 0.05% of all its holdings.

Since May 25, 2017, it had 0 insider buys, and 2 sales for $1.53 million activity.

Tiedemann Wealth Management Llc decreased its stake in Mimedx Group Inc (MDXG) by 97.49% based on its latest 2016Q4 regulatory filing with the SEC. Tiedemann Wealth Management Llc sold 1.73M shares as the company’s stock rose 72.01% with the market. The institutional investor held 44,429 shares of the health care company at the end of 2016Q4, valued at $16.08M, down from 1.77M at the end of the previous reported quarter. Tiedemann Wealth Management Llc who had been investing in Mimedx Group Inc for a number of months, seems to be less bullish one the $1.53 billion market cap company. The stock decreased 0.37% or $0.05 on September 15, reaching $13.56. About 4.74 million shares traded or 105.19% up from the average. MiMedx Group Inc (NASDAQ:MDXG) has risen 107.87% since September 17, 2016 and is uptrending. It has outperformed by 91.17% the S&P500.

Tiedemann Wealth Management Llc, which manages about $5.35B and $1.00B US Long portfolio, upped its stake in Spdr S & P 500 Etf (SPY) by 65,588 shares to 73,044 shares, valued at $16.33M in 2016Q4, according to the filing. It also increased its holding in Sempra Energy (NYSE:SRE) by 43,939 shares in the quarter, for a total of 47,118 shares, and has risen its stake in Schlumberger Limited (NYSE:SLB).

Analysts expect MiMedx Group Inc (NASDAQ:MDXG) to report $0.08 EPS on October, 26.They anticipate $0.05 EPS change or 166.67 % from last quarter’s $0.03 EPS. MDXG’s profit would be $9.03M giving it 42.38 P/E if the $0.08 EPS is correct. After having $0.07 EPS previously, MiMedx Group Inc’s analysts see 14.29 % EPS growth.

More notable recent MiMedx Group Inc (NASDAQ:MDXG) news were published by: Prnewswire.com which released: “MiMedx Signs Definitive Agreement to Divest Stability Biologics Subsidiary as …” on August 18, 2017, also Streetinsider.com with their article: “MiMedx Group (MDXG) Offers Update on Civil Litigation Against Former Employees” published on September 07, 2017, Prnewswire.com published: “MiMedx Announces Its Expectations For Third Quarter Revenue To Exceed $80 …” on September 05, 2017. More interesting news about MiMedx Group Inc (NASDAQ:MDXG) were released by: Seekingalpha.com and their article: “MiMedx Group (MDXG) Presents at Morgan Stanley Global Healthcare Conference …” published on September 13, 2017 as well as Prnewswire.com‘s news article titled: “MiMedx Notified By FDA That It Can Proceed With Phase 3 Investigational New …” with publication date: September 07, 2017.

MiMedx Group Inc (NASDAQ:MDXG) Ratings Coverage

Among 8 analysts covering MiMedx Group (NASDAQ:MDXG), 6 have Buy rating, 2 Sell and 0 Hold. Therefore 75% are positive. MiMedx Group has $2000 highest and $9 lowest target. $13.71’s average target is 1.11% above currents $13.56 stock price. MiMedx Group had 17 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was downgraded by First Analysis to “Underweight” on Tuesday, May 23. The stock of MiMedx Group Inc (NASDAQ:MDXG) earned “Buy” rating by Needham on Monday, June 26. Aegis Capital initiated MiMedx Group Inc (NASDAQ:MDXG) on Tuesday, November 8 with “Buy” rating. The firm has “Buy” rating by Lake Street given on Tuesday, April 19. The company was upgraded on Friday, October 30 by Northland Capital. The stock has “Buy” rating by Needham on Wednesday, August 30. The rating was downgraded by Needham on Wednesday, July 29 to “Buy”. The rating was maintained by Needham with “Buy” on Wednesday, October 14. The stock has “Buy” rating by Piper Jaffray on Thursday, July 13. The firm has “Buy” rating given on Friday, July 14 by Needham.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.